Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
[A heterozygous point mutation G13328A in antithrombin gene causes thrombosis].
|
16620552 |
2005 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report 22 novel antithrombin gene (SERPINC1) mutations associated with antithrombin deficiency in 17 French and five German families.
|
16705712 |
2006 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Use of recombinant human antithrombin concentrate in pregnancy.
|
24082793 |
2013 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
Up to 80% of patients with antithrombin deficiency have SERPINC1 gene defects, mostly (90% of the 315 gene defects described so far) point mutations or small deletions or insertions affecting the 7 exons or flanking regions.
|
30005274 |
2018 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Two novel gene mutations in type I antithrombin deficiency.
|
11794707 |
2001 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Two SERPINC1 mutations causing type II antithrombin deficiency, Arg79Cys and Ser158Pro, were prevalent in the population group.
|
24162787 |
2014 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.
|
28300866 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)
|
7989582 |
1994 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Three novel mutations of antithrombin inducing high-molecular-mass compounds.
|
7981186 |
1994 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.
|
7959685 |
1994 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This thrombus formation was attributed to antithrombin deficiency caused by a novel SERPINCI gene mutation (AT III Akita, M352R).
|
15338392 |
2004 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This study demonstrates that the search for large gene rearrangements in SERPINC1 can be a useful diagnostic approach, particularly in patients with type I antithrombin deficiency without mutations in SERPINC1.
|
25083771 |
2015 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
These results are consistent with previously published data suggesting that mutation of the antithrombin III structural gene is the cause of inherited antithrombin III deficiency in some families.
|
3162535 |
1988 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Therefore, this is the first mutation affecting a regulatory region of the SERPINC1 gene associated with antithrombin deficiency.
|
22234719 |
2012 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The molecular basis of antithrombin deficiency in Belgian and Dutch families.
|
9759613 |
1998 |
Antithrombin III Deficiency
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
The level of antithrombin III was often decreased in patients with preeclampsia - (32.4%), then in the other patients - (17.2%) (P=0.04), but no patient was diagnosed with antithrombin III deficiency (diagnosis: level<60%).
|
28792912 |
2018 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The analysis of latent antithrombin in 141 unrelated patients with antithrombin deficiency carrying 89 different SERPINC1 mutations identified four cases with higher levels than that of controls: p.Pro439Thr, p.Pro461Ser, p.Met283Val, and p.His401Tyr, the last also with circulating polymers.
|
28229161 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Site-directed mutagenesis of alanine-382 of human antithrombin III.
|
2013320 |
1991 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow.
|
3162733 |
1988 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
SERPINC1 gene mutations in antithrombin deficiency.
|
28317092 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation.
|
16908819 |
2006 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Pleiotropic effects of antithrombin strand 1C substitution mutations.
|
1469094 |
1992 |